The present invention relates to a device that combines microtechnology and ultrasonic waves as a non-invasive method for the selective separation and extraction of particles in polydispersed suspensions, containing microelements having different physical characteristics (size, density or compressibility) for any concentration level, being mainly applicable to the field of biomedicine and biotechnology.
In the last decade, different techniques have been proposed for manipulating or separating suspended particulate matter in different fields of technological application, particularly biotechnology and medicine. At present, the separation of particles is of particular interest to medicine in applications related to blood donations, dialysis processes and laboratory analyses, in addition to the recycling and/or washing of blood after surgical operations.
The application of standing acoustic waves to suspensions produces the effect of transporting particles towards certain equilibrium zones related to the node distribution and maximum acoustic pressure values established by the standing wave generated in the medium. An acoustically induced primary radiation force is exerted on each particle, the magnitude of which varies proportionally to operating frequency. The distance travelled by a particle subjected to this force to reach the nearest acoustic equilibrium position is shorter as the distance between nodes and maximum pressure values becomes shorter. These are defined by the wavelength, which is inversely proportional to acoustic frequency. Therefore, from a theoretical viewpoint, it is simpler to concentrate particles at higher frequencies.
This non-invasive transport mechanism is well known in the field of ultrasound and, during the last decade, has given rise to the development of several attempts to manipulate and/or separate particles. Different techniques for separating particles from a liquid or other fluid using this phenomenon have been proposed. Typically, the fluid circulates through a duct or channel wherein a standing acoustic wave transversal to the length of the channel is established. As a result, the particles move to form concentration bands along the wave equilibrium positions within these ducts.
One aspect of the invention is constituted by a micro-device for selective and non-invasive separation and extraction of particles in polydispersed suspensions, hereinafter referred to as the micro-device of the invention, characterized in that it comprises the following components, integrated in a chip substrate of acoustically soft material:
One particular embodiment of the invention is constituted by the micro-device of the invention, wherein the constituent materials of the chip substrate, preferably an epoxy resin SU-8 whereon the channel is embodied and the acrylic PMMA (methyl polymethacrylate) substrate have an acoustic impedance of 3.3 MRayls, and where the ultrasonic transducer b) may be a small piezoelectric ceramic or rectangular piezoelectric composite, preferably a 1-3 class piezoelectric composite.
Another aspect of the invention is constituted by the manufacturing process of the micro-device of the invention, hereinafter referred to as the manufacturing process of the micro-device of the invention, based on the photolithography technique in accordance with the design described in
Therefore, another aspect of the invention is constituted by the use of the micro-device of the invention, hereinafter referred to as use of the invention, in a process for the selective and non-invasive separation, washing and/or classification of particles in polydispersed suspensions.
Another more particular aspect of the invention is constituted by the use of the invention wherein the particles consist of cells belonging, by way of example and without limiting the scope of the invention, to the following group: virus, prions, prokaryotic (bacteria, yeasts, fungi, algae, etc.) and eukaryotic cells.
A more particular embodiment of the invention is constituted by the use of the micro-device of the invention for the selective separation and isolation of eukaryotic cells, preferably human cells and, more preferably, tumour cells, blood cells (erythrocytes, platelets, macrophages and lymphocytes), stem cells or parent cells, whether somatic or embryonic or of another kind present in body fluids, such as for example: blood, urine, cerebrospinal liquid or present in other types of biological samples from biopsies.
A micro-device has been developed for the ultrasonic separation and extraction of particles and cells in suspension by means of a multi-layer-type ultrasonic resonator having a modified lambda-quarter channel with singular characteristics. Specifically, it has a particular geometric configuration, both in terms of the central treatment channel and the asymmetrical spatial distribution of the sample inflow and outflow channels with respect to the central treatment channel. The inventors have also discovered the importance of this last characteristic, which reinforces separation effectiveness, as described later in the text.
The present invention is based on the fact that the inventors have observed that the application of an activation wave generated by a transducer in parallel with a central treatment channel produces a standing wave therein perpendicular to the direction of flow, with a pressure node disposed in an intermediate position between the centre of the channel and the reflector wall in the region occupied by the pure fluid bed, which occupies the length of the acoustically affected treatment channel.
The device is activated by means of an ultrasonic actuator or transducer, for example a small, rectangular, piezoelectric ceramic or 1-3 class piezoelectric composite having a very low surface vibration amplitude, less than 10% at the ends and practically null in the middle. Said piezoelectric composite is formed from piezoelectric fibres embedded in a polymer matrix to constitute a composite of, for example, 1-3 class. In this manner, the coupling between the lateral modes associated with its dimensions is minimised, together with transmission thereof through the chip to the channel and therein.
One of the characteristics of the invention is that the ultrasound source is disposed in contact with the chip, on one of the outer edges, parallel to the treatment channel, to transmit the acoustic energy through its thickness in a direction perpendicular to the length of the treatment channel. The piezoelectric element is partially glued on one of its metallised surfaces to one of the outer edges of the chip of the micro-device, particularly the edge nearest the central treatment channel embodied on the chip, parallel thereto. In this manner, it transmits the acoustic energy through the successive layers that form the multi-layer system, establishing a standing wave with a pressure node inside the treatment channel, perpendicular to the direction of flow.
The location of the treatment channel with respect to the device assembly is important but not decisive; specifically, the inventors have developed two chip configurations with two distances from the channel to the edge of the chip where the ultrasonic actuator is disposed to improve pressure node stability therewithin:
Both devices achieve an effective separation and extraction process, although certain optimisation of node stability in the channel can be observed in the second configuration. In the resonance of the multi-layer system, each and every one of the components (composite-chip-channel-chip) is involved in the establishment of the node inside the channel.
Therefore, the standing wave generated through the successive layers of the device is redistributed with respect to the first configuration, optimising the position of the pressure node inside the channel and enabling optimisation of the acoustic energy of the device. As opposed to our device, most technological developments are symmetrical and do not allow this possibility, given that resonance is formed inside the channel and the external layers are not so influential. The configuration versatility of our multi-layer system considerably increases the operating parameters for possible technological enhancements.
An acoustic pressure gradient is generated on the lateral walls of the channel, around the node disposed in an intermediate position between the centre of the treatment channel and the reflector walls, in the region occupied by the pure fluid bed throughout the length of the acoustically affected channel. This pressure node is produced at a distance of approximately ⅓ of the channel width from the reflector wall and ⅔ of the channel width from the opposite wall, respectively. Therefore, the pressure distribution established in this perpendicular direction to sample flow throughout the length of the channel originates a radiation force that acts in a specific manner on each suspended particle, perpendicularly to the direction of flow. However, its transport effect is limited only to those particles with a certain size, density or compressibility which, being susceptible to the acoustic conditions applied and selected in each case according to the specific type of application, are accelerated by the action of said force.
The strategic location of this acoustic equilibrium zone that constitutes the pressure node in the pure fluid bed, obliges the acoustically dragged particles to cross the separation interface between the two fluid media, thereby abandoning the suspension to be collected in the pure fluid, also hereinafter referred to as collector fluid, wherefrom they are extracted through one of the outflow channels.
The inventors also point out the importance of the strategic location of the node, relatively far from the reflector wall, as it represents an innovation with respect to “lambda-quarter resonators”, wherein said node is located next to the reflector wall. This prevents problems caused by the adherence of the particles to said wall and favours the concentrated circulation thereof towards the channel exit, thereby avoiding obstruction problems. Additionally, the pressure node occupies a length along the channel similar to that of the ultrasonic actuator (length occupied by the piezoelectric ceramic or 1-3 class piezoelectric composite).
Another novelty of the present invention relates to the asymmetrical layout of the inflow and outflow channels stemming from the central treatment channel, which allows the ultrasonic transduction system to exert its influence through the chip on a wider area of the channel than that usually affected in these types of separators, which includes branching. This strategic spatial layout increases the possibility of disposing the ultrasound source (gluing area of the piezoelectric ceramic or piezoelectric composite) on the chip substrate, together with the action zone in the treatment channel, including the region that branches off towards the two outflow branches. In this region, geometrically different to the rest of the channel, the resulting radiation force is directed towards the channel exit wherethrough the particle collector fluid abandons the device, increasing selective separation efficiency.
This widening of the acoustic action zone ensures that the selected particles flow out through the desired channel, optimising separation and extraction effectiveness thereof from their initial medium, the suspension.
Another characteristic of this invention is the ultrasonic treatment frequency, 1 MHz, less than usual for micro-devices of this kind (which normally operate at a minimum of 2 MHz, most above this value). However, this frequency may vary, conveniently scaling the transversal dimensions of the central treatment channel, which must vary proportionally to the changes produced in wavelength (inversely to acoustic frequency). Therefore, low frequencies allow handling of greater treatment volumes. However, in the case of frequencies below 500 kHz, the acoustic cavitation threshold (which consists of the generation of micro-bubbles with strong and fast implosion effects in the medium) is also lower than that of higher frequencies. Due to this, the acoustic energy variability range for generating ultrasonic transport without causing damage to the suspended microelements is more restricted. Additionally, it must be taken into account that the radiation force increases linearly with acoustic frequency, due to which the volume benefits reported by the use of resonator devices at low frequencies have the drawback of higher energy consumption. In the case of the micro-device of this invention, ultrasound was applied at a lower than usual frequency, specifically at 1 MHz, for which, however, the acoustic cavitation threshold is high, demonstrating its viability and allowing a treatment volume at least twice as large as in the case of devices intended for resonation at 2 MHz. Therefore, the invention provides two advantages related to this acoustic parameter with respect to existing resonator micro-devices at higher frequencies; these refer to an increase in the aforementioned treatment volume and, consequently, a decrease in the restrictions associated with measurement adjustment precision (basically channel walls).
Another novelty of the micro-device of the invention is its constituent material, a chip integrated by two parallel-coupled materials: PMMA (methyl polymethacrylate) used as the constituent base substrate of the channel bottoms (with a thickness of approximately 900 μm) and a lamina of photodefinable epoxy SU-8, disposed on said substrate (with a thickness of 330 μm), whereon the channel is embodied. In this regard, special reflectors or similar have not been used for the walls of the central treatment channel and, on the contrary, the good behavior of the SU-8 material has been confirmed, which in the device constitutes a substantial part of the resonant multi-layer system. Its low acoustic impedance allows coupling of its resonant modes to those of the channel, without requiring special reflectors or similar for the treatment channel walls. Therefore, use of the polymeric material SU-8 as a reflector element for establishing the standing wave inside the channel and the advantageous applicability of these acoustically soft acrylic materials have been experimentally validated. Additionally, the good acoustic behavior of the constituent material of the channel bottoms, PMMA, has been verified as being a transmitter of ultrasonic energy with acoustic characteristics similar to those of SU-8 and good mechanical-acoustic coupling thereto. They are two polymeric materials which are easy to handle and low in cost. Both materials have low acoustic impedance (not higher than three times that of water and at least five times lower than that of metal) and allow easy handling thereof for creating the channels, in addition to the evident advantage of their lower cost compared to other substrates used in micro-devices of this kind, such as silicon, which is much more rigid from an acoustic viewpoint and more expensive. Overall, they offer interesting economic advantages.
The model used for experimentation, which is described in the second practical embodiment, is a model formed from polystyrene microparticles of different sizes and densities which could, for example, mimic the physical and acoustic characteristics of two types of cells: erythrocytes and tumor cells exfoliated from peripheral blood, initially flowing together in a fluid similar to blood plasma, in addition to any other sample containing microelements of these characteristics.
Worthy of mention is the high effectiveness of the selective separation and extraction of the particles with the greatest diameter obtained in the experiments carried out using the device of the invention. The repetitive behavior is due to the individual action of the acoustic radiation force on each particle, regardless of their concentration in the suspension. The effectiveness of the action is valid for both high concentrations and extremely diluted suspensions, where other separation techniques show a sharp reduction in action sensitivity and effectiveness.
In summary, of all the previously described novelties, the simplicity and effectiveness of the micro-device stand out: simplicity due to both the ultrasound source (consisting of a piezoelectric ceramic or piezoelectric component) and the geometry of the treatment channel and its inflow and outflow branches, in addition to the constituent materials of the chip of the device: plastic materials SU-8 (whereon the channel is embodied) on a PMMA substrate that constitutes the channel bases, in addition to its effective results.
Therefore, one aspect of the invention is constituted by a micro-device for the selective and non-invasive separation and extraction of particles in polydispersed suspensions, hereinafter referred to as micro-device of the invention, characterized in that it comprises the following components, integrated in a chip substrate of acoustically soft material:
Use of the term “particle” in “polydispersed suspensions” in the present invention refers to a suspension with particles of different physical characteristics (size, density or compressibility, among others), comprising inorganic or organic microelements such as cells, preferably eukaryotic cells, more preferably human cells, microorganisms or other types of microelements present in biological fluids with parameters of the same order.
Use of the term “chip made of acoustically soft materials” refers to materials with an impedance far below that of other materials or media such as metals or glass (at least five times lower) and, fundamentally, no more than three times the impedance of liquid media (usually delimited within a variability range that generally varies, save for exceptions, between 0.8 MRayls and 2.6 MRayls). The concept of “soft” therefore refers to the impedance relationship between the constituent material of the treatment channel walls and the fluids circulating therewithin, but having sufficient capacity to produce reflections of the acoustic wave to establish standing waves.
Therefore, any soft material, preferably an acrylic material, having acoustic properties similar to SU-8 or other plastic elements may be used as a material for manufacturing the chip substrate of the micro-device of the invention whereon to embody the channel, due to its similarity in terms of transmission of acoustic energy therethrough and similar reflection responses on the channel walls.
A particular embodiment of the invention is constituted by the micro-device of the invention, wherein the constituent materials of the chip substrate, preferably epoxy resin SU-8 whereon the channel is embodied and the acrylic substrate PMMA (methyl polymethacrylate), have an acoustic impedance of 3.3 MRayls, and where the ultrasonic transducer b) may be a small piezoelectric ceramic or piezoelectric composite, preferably one of 1-3 class.
Another aspect of the invention is constituted by the manufacturing process of the micro-device of the invention, hereinafter referred to as manufacturing process of the micro-device of the invention, which is based on the photolithography technique in accordance with the design described in
The present micro-device can be easily manufactured by a person skilled in the art with the knowledge and designs indicated in the present invention and with the current state of the art. Additionally, the design of the micro-device of the invention can be enhanced by introducing additional empty channels strategically disposed around the central channel to minimize the loss of acoustic energy transmitted through the PMMA chip substrate and SU-8 material. These additional elements may easily be incorporated in the design of the device of the invention by repeating steps b), c) and d) of the manufacturing process of the device and adding two sealed air-filled channels beneath the central channel and parallel thereto. There is an air-filled channel disposed both beneath and next to the fluidic treatment channel where the separation takes place. In this manner, the ultrasound signal used for separation is disposed in the desired confined position, thereby minimizing losses. The configuration of the central channel can also be enhanced by:
Additionally, the operation of the micro-device can be enhanced by slightly modifying operating frequency, as the system shows well-differentiated micro-manipulation capabilities making slight variations in frequency around the core operating frequency for which it was designed. Increases in frequency of less than 12% of its core value allow modification of the equilibrium position and collection of the microelements inside the channel towards the desired position in accordance with the application to be developed. This characteristic gives the micro-device broad application versatility.
On the other hand, the operation of the micro-device can be enhanced by broadening the operating frequency range, as the system has micro-manipulation capabilities by making slight variations in frequency around the core operating frequency for which it was designed. Increases in frequency of less than 12% of its core value allow modification of the equilibrium position and collection of the microelements inside the channel towards the desired position in accordance with the application to be developed. This characteristic gives the micro-device broad application versatility.
On the other hand, the micro-device of the invention can also be manufactured using hot-stamping techniques combined with a subsequent gluing process, in the following manner:
On the other hand, the frequency range applicable to the micro-device of the invention for both organic and inorganic suspensions is broad, although certain considerations must be taken into account in the case of organic suspensions, as explained hereunder. One variation in ultrasonic frequency implies a scaling process in the dimensions of the device. Given that operation of the micro-device is based on the acoustic resonator model in the direction of channel width, the spatial characteristics associated with this lateral dimension of the treatment micro-channel must be varied in inverse proportion to the acoustic frequency. Although the radiation force induced on each micro-element of the suspension is directly proportional to the frequency, the decrease in the acoustic cavitation energy threshold must be taken into account in the case of organic suspensions with low frequency levels (in the order of kHz) so as to avoid cell damage. This undesired phenomenon is favored by low frequencies, due to which there would be limitations to the application of the invention below 500 kHz. On the contrary, the increase in frequency linearly increases the magnitude of the radiation force and allows a reduction in the acoustic energy levels required to generate selective ultrasound-based transport. For this reason, nearly all the devices developed to date operate at between 2 MHz and 5 MHz. In contrast, an increase in these frequencies implies a scaled reduction in the lateral dimensions of the treatment channel, which must vary proportionally to the changes induced in the acoustic wavelength, raising the cost of the manufacturing processes of these devices due to the need for precision.
The results obtained using this model allow application of the device in the sphere of particle separation and isolation, with important applications in agrobiotechnology, biotechnology applied to human and animal health such as, for example, separation and isolation of cells, preferably human, and diagnostic and treatment processes, for example, cell or gene therapy treatment of mammal diseases, preferably those of human beings.
Therefore, another aspect of the invention is constituted by the use of the micro-device of the invention, hereinafter referred to as use of the invention, in a process for the selective and non-invasive separation, washing and/or classification of particles in polydispersed suspensions.
Another more particular aspect of the invention is constituted by the use of the invention wherein the particles consist of cells belonging, by way of example and without limiting the scope of the invention, to the following group: virus, prions and both prokaryotic (bacteria, among others) and eukaryotic cells.
A more particular embodiment of the invention is constituted by the use of the micro-device of the invention for the selective separation and isolation of eukaryotic cells (such as algae, fungi—including yeasts—), preferably human cells and, more preferably, tumour cells, blood cells, stem cells or parent cells, whether somatic or embryonic or of other kinds present in body fluids, such as for example: blood, urine, cerebrospinal liquid or those present in other types of biological samples from biopsies.
Specific biomedical processes or applications, whether in relation to diagnosis or treatment, where the micro-device of the invention can be used are those related to blood donations, plasmapheresis, dialysis processes and laboratory analyses, in addition to recycling and/or washing of blood after surgical operations, where the separation and concentration of certain types of cells, for example erythrocytes and platelets, is required.
Another example is constituted by the use of the micro-device of the invention in a human disease diagnosis and/or treatment process for the selective separation and extraction of damaged or altered cells of patients, which can be repaired ex vivo and re-administered to the patient.
A specific field of biomedical application is oncology, where it can be used as a diagnostic and prognostic tool for reproducing the selective separation and extraction of circulating tumour cells in peripheral blood (CTC) of oncology patients with solid tumours of different tissular origin and at different stages of the disease.
The clinical use demonstrated to date in the quantification of the number of circulating tumour cells in peripheral blood focuses on the following aspects:
The analysis systems used in these studies are based on positive immunomagnetic separation using monoclonal antibodies and subsequent analysis using fluorescence microscopy. These applications have obtained the approval of the Food and Drug Administration (FDA) for use thereof in clinical practice in the United States.
The use of both applications for other types of tumours is becoming widespread. Likewise, there are preliminary studies that indicate the potential use of the analysis of the number of CTC as an early marker for relapses in colorectal cancer (Soto J L, Garrigos N, Gallego J, Guaraz P, Garcia-Bautista M, Castillejo A, Gomez A, Casado-Llavona C, Rodriguez-Lescure A, Carrato A. Toward a circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients. Eur J Cancer Supplements. 3 (2):187; 2005).
One of the main advantages of the device of the present invention is the real possibility not only of effectively separating CTC—which would allow easy counting thereof—but also of being able to isolate said cell population in viable conditions for subsequent analyses—both descriptive on a genetic level and gene expression profiles—and ex vivo functional behavior studies. To date, it is the only known device capable of offering said possibility with such high effectiveness.
The concept of CTC as an affordable and non-invasive tumour biopsy has the added value of the possibility of functionally characterizing the behavior of said cells with respect to their sensitivity/resistance to the available therapeutic arsenal as a personalized system for selecting the most effective treatments for each patient.
The real and potential clinical use of the device is therefore of great importance to clinical practice, offering highly valuable information for better managing patients with different diseases.
The first practical embodiment describes a first prototype of the micro-device of the invention.
In the prototype shown in
The prototype of the micro-device has been designed and manufactured in such a manner as to comprise a chip (100) with an integrated system of four micro-channels (160, 162, 170 and 180), centred around a central treatment channel (110), two on either end thereof, asymmetrically disposed, for both inflow and outflow of two media circulating in parallel under laminar regime along the channel (110) (see
As can be observed in
Photograph 3.a shows the device from above and photograph 3.b shows the chip structure edgewise with the two mechanically coupled polymeric materials.
As can be observed in the photograph of
More specifically, channel width is 390±4.6 μm (1.06 times a quarter of the wavelength for 1 MHz). The pressure node is disposed at a distance of 117±4.6 μm from the reflector wall, in the region occupied by the pure fluid bed, external to the suspension. Therefore, the channel has a cross-section of 0.0975 mm2 and a wavelength that can vary freely, although in the specific case of the invention it is 1 cm. Therefore, channel volume is 0.975 mm3.
a) Deposition and definition of a photodefinable polymer layer on the surface of an independent substrate; b) Deposition and definition of a photodefinable polymer layer on the surface of an independent substrate covered by a non-stick material; c) Sealing of wafer 1 and wafer 2; and d) Removal of the wafer covered by non-stick material.
a) Preparation of a mould wherein the designs of the desired channels are included, b) Molding of the substrate to be used, using the mould obtained in a), under the action of pressure and/or temperature, and c) Sealing of the substrate by gluing to another plastic material under the action of pressure and/or temperature and/or surface activation by oxygen plasma.
In the second embodiment, the use of the micro-device of the invention in the separation of cell-mimicking microparticles is described.
For the microfluidic control of the micro-device of the invention, a constant-pressure injection pump with simultaneous application capacity to three syringes of different volumes (between 10 μl and 110 ml) was used to control the flow of both media at each of the entrances (160 and 162). The suspension (150) and collector fluid (124) were simultaneously injected at the same pressure using syringes of the same volume (5 ml each) through these entrances (160 and 162), respectively.
The ultrasonic separation of the selected particles and transport thereof to the pressure node, in the collector fluid (124) bed, were monitored in real time using filmings of microscopic resolution made with a CCD camera coupled to an optical lens assembly with a resolution of 1.17 μm/digital pixel. The width of the fluidized bed occupied by the suspension was maintained at around ½ of the channel (110) width.
The model used for experimentation in this example is a polystyrene microparticle model with sizes and densities that mimic the physical and acoustic characteristics of two types of cells: erythrocytes and tumour cells exfoliated from peripheral blood, initially flowing together in a fluid similar to blood plasma.
The physical and acoustic characteristics of this fluid, such as density and acoustic propagation speed thereof, are described in the paper (Cousins C M, Holownia P, Hawkes J J, Limaye M S, Price C P, Keay P, Coakley W T, Plasma preparation from whole blood using ultrasound. Ultrasound Med Biol 26:881-888, 2000), in addition to those of the erythrocytes (Duck F A, Physical properties of tissue: a comprehensive referente book, Academia London, 1990, Haider L, Snabre P, Boynard M, Rheology and ultrasound scattering from aggregated red cell suspensions in shear flow, Biophysical Journal, Vol. 87, 2322-2334, 2004). On the contrary, the non-existence of bibliographic references to these properties for circulating tumour cells in peripheral blood obliged us to determine said data indirectly through the development of an experimental induction model. To this end, we resorted to the acoustic characterisation of two liquid media frequently used in oncology laboratories for cell separation by centrifugation and density gradient: Ficoll® and another liquid medium not technically defined but used in an experimental device called Oncoquick®, which is very effective in the separation of tumour cells due to its density, whereon the tumour cells exfoliated from peripheral blood float [Rosenberg R, Gertler R, Friedrichs J, Fuehrer K, Dahm M, Phelps R, Trovan S, Nekarda H, Siewert J R. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumour cells in blood. Cytometry 49; 150-158. 2002].
The possible variability margin for tumour cell density was derived from the density and sound propagation speed measurements in both liquids: 1.030 gr/cm3<ρ (tumour cells)<1.055 gr/cm3, with an uncertainty degree of less than 5% of the minimum value. Based on these data and taking into account the approximately linear dependence for biological microelements, their compressibility was estimated selecting, for this example, particles with a density of 1.05 gr/cm3, as being representative of tumour cells.
Once the tumour cells were characterized using this experimental model, they were mimicked by polystyrene particles with selected diameters of 20 μm. Although the variability range of these cells is very broad (definable between 10 and 40 μm), this size was chosen as a standard value.
In this manner, we proceeded to introduce and analyses “bi-disperse” aqueous suspensions, i.e. containing two particle populations with a diameter of 6 and 20 microns, respectively, in different concentrations and subjected to ultrasound in the device. The results of the selective separation and extraction of the large particles can be clearly observed in
In accordance with
In accordance with
The results of the selective separation of the 20 μm were positive for all the tests conducted on the samples injected through the central treatment channel (within a range of variability between 0.06 mm/s and 1.4 mm/s) at different flow speeds, always under the laminar regime required in microfluidics. Bi-disperse aqueous suspensions were used: with different volumetric concentrations of small particles (6 μm), not quantified, and large particles with diameters of 20 μm at a very low concentration, always less than 1%. All the experiments were conducted at the frequency determined by channel width, strategically determined based on the resonant frequency of the PZ26 piezoelectric ceramic: 1 MHz. Deionized water was always used as the pure fluid.
More specifically, the two media were introduced into the central channel in parallel: a suspension (150) wherefrom particles having certain characteristics (101) were extracted (specifically, particles with a diameter of 20 μm and a density of 1.05 gr/cm3) and a liquid fluid (deionized water) (124), through two channels (160 and 162), both having the same cross-section (0.049 mm2) and integrated in the chip of the invention, each of which occupy half of the section of the central channel (110). The two media flow through the channel (110) in parallel and under laminar regime along their corresponding bed: the pure fluid that will collect the particles (101) along a fluidized bed (124) and the suspension along the bed (122) that occupies the other part of the channel (110) section, keeping the interface that separates them (120) stable. This behavior can be observed in the photographs of
For supply voltages of 15 volts applied to the ultrasonic transducer from a continuous signal generator, the 20 μm particles (101) are subjected to a radiation force and are rapidly transported perpendicularly to the continuous flow of the suspension along the channel (110) under the action of the ultrasounds towards the pressure node, located in the region occupied by the pure fluid (water) (124) (
On the contrary, the small 6 μm particles contained in the suspension (107) at a high concentration are not affected by the acoustic field and do not undergo acoustic dragging, given that the radiation force exerted thereupon is much smaller due to being proportional to the third power of the radius, which is three times smaller than that of the large particles (101). In this manner, the particles continue circulating in the suspension along their initial fluidized bed without altering their paths. Finally, they abandon the device through the suspension outflow channel.
The rest of the suspension components (150) are not affected by the acoustic field, will not cross the interface (120) between the two media (150 and 130) and continue circulating, flowing along their corresponding bed (122) throughout the micro-fluidic channel (110), until reaching the branching point (175) as of which they will abandon the device through the outflow channel-branch (170).
Worth mentioning is the high degree of effectiveness of the selective separation and extraction of the large 20 μm particles obtained during the experiments with the device of the invention.
For example, in experiments where the samples were injected into the treatment channel using 5 ml syringes at a circulation speed of 1.4 mm/s (12 minutes for emptying 1 ml) in the channel, no negative action results were found wherein large 20 μm particles abandoned the device through the suspension outflow channel, but rather were continuously transported towards the collector fluid, through the outflow channel of which they were discharged.
A qualitative analysis of visualization of the samples collected at the exit of the two channels (170) and (180) confirms the effectiveness of the selective separation and extraction of the 20 μm particles of the suspension wherein they were immersed prior to ultrasonic treatment. The liquid collected for one minute from the channel wherethrough the suspension subjected to the acoustic wave is discharged does not contain 20 μm particles but, however, reveals a very high presence of smaller particles, with diameters of 6 μm. On the contrary, the liquid collected at the exit of the channel (180) contains 20 μm polystyrene particles which, as can be previously observed in the central channel (110) and in the branching zone (175), are acoustically separated from their initial suspension and extracted to the collector fluid (124), abandoning the device through the channel (180).
These experiments were conducted at a very low concentration for 20 μm particles, far below 1% of their volumetric concentration, simulating real situations of tumour cells exfoliated from blood. The repetitive behavior found in this particle population at different concentrations (always less than 10%) is due to and understood as the individual action of the acoustic radiation force exerted upon each particle, regardless of its concentration in the suspension. The effectiveness of the action is valid for both high concentrations and extremely diluted suspensions, where other separation techniques show a sharp reduction in sensitivity and effectiveness.
Number | Date | Country | Kind |
---|---|---|---|
P200703248 | Dec 2007 | ES | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/ES2008/070230 | 12/5/2008 | WO | 00 | 7/20/2010 |